scholarly journals MRI and PET Scans for Primary Staging and Detection of Cervical Cancer Recurrence

2010 ◽  
Vol 6 (2) ◽  
pp. 251-269 ◽  
Author(s):  
Sidath H Liyanage ◽  
Charlotte A Roberts ◽  
Andrea G Rockall
2004 ◽  
Vol 14 (5) ◽  
pp. 846-851 ◽  
Author(s):  
V. Moutardier ◽  
G. Houvenaeghel ◽  
M. Martino ◽  
B. Lelong ◽  
V. J. Bardou ◽  
...  

Pelvic recurrence of cervical cancer is a life-threatening situation and only local control can provide hope for remission. The aim of this study was to evaluate the role of surgery in the treatment of cervical cancer recurrence. This retrospective study analyzed a series of 70 patients who underwent resection of cervix locoregional recurrence. Thirteen patients had palliative salvage surgery for pelvic complications. Twenty-nine resections were considered as curative. Fifty recurrences required pelvic exenterations. The hospital mortality rate was 9% and the morbidity rate was 44%. Overall 5-year actuarial survival rate was 23%. Survival was significantly higher: (a) after curative resection and (b) after centropelvic recurrence resection. Local control was obtained in 48% of the cases and 13 patients are alive with a median follow-up of 75 months. In conclusion, the results of this small and heterogen series seem to justify an attempt to resection for centropelvic recurrences whenever possible. Palliative surgery should be reserved to salvage therapy and highly selected patients.


2008 ◽  
Vol 5 (2) ◽  
pp. 125-127 ◽  
Author(s):  
Jiaxin Yang ◽  
Jinhui Wang ◽  
Zhaohui Zhu ◽  
Keng Shen ◽  
Bocheng Wang

2003 ◽  
Vol 13 (6) ◽  
pp. 856-862 ◽  
Author(s):  
D. Cantu De León ◽  
C. Lopez-Graniel ◽  
M. Frias Mendivil ◽  
G. Chanona Vilchis ◽  
C. Gomez ◽  
...  

The purpose of this retrospective study of 118 patients with squamous cell cervical cancer from January 1990 to December 1993 was to evaluate angiogenesis as predictive factor of recurrence in cervical cancer stages II–III treated with standard radiotherapy. Microvessel density (MVD) was evaluated and correlated with other prognostic factors. MVD was greater than 20 in 67.8% of patients with recurrence (P = 0.002) in comparison to 39% of patients without. Disease-free survival was shorter in stage IIA and MVD >20 (P = 0.0193) as well as for stage IIB (P < 0.05), but not for IIIB (P = 0.1613). Global survival was significantly shorter when MVD was >20 (P = 0.0316). For stage IIA and MVD >20 survival was shorter (P = 0.0008) for stage IIB (P < 0.05) but not for IIIB (P = 0.14). Patients younger than 40 years and MVD >20 had poorer disease-free interval and survival (P = 0.0029). MVD in patients with squamous cell cervical cancer stage II and age younger than 40 may play a role in predicting recurrence and survival.


2020 ◽  
pp. jnmt.120.247080
Author(s):  
Nghi Co Nguyen ◽  
Sushil Beriwal ◽  
Chan Hong Moon ◽  
Alessandro Furlan ◽  
James M. Mountz ◽  
...  

RSC Advances ◽  
2015 ◽  
Vol 5 (129) ◽  
pp. 106325-106332 ◽  
Author(s):  
Yue Ma ◽  
Xue Wang ◽  
Shan Zong ◽  
Zhiyun Zhang ◽  
Zhigang Xie ◽  
...  

Electrospun nanofibers co-loaded with cisplatin and curcumin effectively reduce the risk of local cervical cancer recurrence after surgery.


2020 ◽  
Vol 159 ◽  
pp. 173
Author(s):  
A.D. Borgstadt ◽  
C.A. Mathews

Sign in / Sign up

Export Citation Format

Share Document